Deals of the week: Bukalapak gets more GIC funds; EDBI backs cancer biotech

THESE South-east Asian tech deals made headlines in the past week:

1. Bukalapak raises US$234 million led by Microsoft, GIC and Emtek

According to a sale document seen by Reuters, the funding round for the Indonesian e-commerce unicorn also included South Korean web portal Naver and SC Ventures, the investment arm of Standard Chartered.

Bukalapak is reportedly planning to list in Indonesia before eyeing a merger with a special purpose acquisition company (SPAC) in the US.

2. Biotech startup Immunoscape raises US$14 million

Immunoscape, which specialises in cancer treatment, raised US$14 million co-led by EDBI and existing investors US-based Anzu Partners and Japan-based University of Tokyo Edge Capital Partners.

The EDBI investment was made through the S$285 million Special Situation Fund for Startups. The money will be used to scale up operations in Singapore and the US, as well as to improve the startup's immune-profiling technology.

3. Genesis Alternative Ventures closes US$80 million debt fund

The firm's first venture debt fund was anchored by family office Sassoon Investment Corp, which is a shareholder in The Coffee Bean & Tea Leaf. Other investors include Japan's Aozora Bank, Korea Development Bank and Hong Kong multi-asset investment firm Silverhorn Group.

Seattle-based global investment impact fund Capria Fund and Indonesia's PT Bank CIMB Niaga also invested in the fund.

4. Vietnamese electric motorbike startup Dat Bike raises US$2.6 million

The company's pre-Series A round was led by Jungle Ventures. Other investors included Wavemaker Partners, Hustle Fund and iSeed Ventures.

The funds will be used for research and development, improving customer-facing operations and expanding the Dat Bike team.